Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
06/13/1989 | EP0305384A4 Water soluble polyvinyl lactam-drug complexes. |
06/13/1989 | CA1255679A1 2-(pyridyl and imidazolyl)-indoles |
06/07/1989 | EP0319506A2 Novel platelet-aggregation inhibitor peptide derivatives |
06/07/1989 | EP0319315A2 The von Willebrand factor binding domain of factor VIII |
06/07/1989 | EP0319073A2 Cyclo-octane neuroprotective agents |
06/07/1989 | EP0319052A2 Mutant acidic fibroblast growth factor |
06/07/1989 | EP0318902A2 Use of linear annelated tricyclics as inhibitors of erythrocyte aggregation |
06/07/1989 | EP0318795A2 Pharmaceutically active pteridin derivatives |
06/07/1989 | CN1033289A Preparation of monostrepurokinase |
06/06/1989 | US4837319 1-substituted alkyl-1,2-dihydro-2-pyrazinone derivatives |
06/06/1989 | US4837223 (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide compositions |
06/06/1989 | US4836987 Interior coating of lignan derivative |
06/06/1989 | CA1255311A1 Isoindolinyl-alkyl-piperazines |
06/06/1989 | CA1255299A1 Guanidinothiazole derivatives containing alkylene bridges, a process for their preparation and their use as medicaments |
06/01/1989 | WO1989004668A1 Potentiation of erythropoiesis |
05/31/1989 | EP0318451A2 DNA clone of human tissue factor inhibitor |
05/31/1989 | EP0318446A1 Amino acid composition for parenteral nutritional support |
05/31/1989 | EP0318201A2 Inhibition of arterial thrombotic occlusion or thromboembolism |
05/31/1989 | EP0318090A2 Tert-butyl phenyl compounds as anti-inflammatory agents |
05/30/1989 | US4835154 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors |
05/30/1989 | US4834983 Pharmaceutical compositions |
05/30/1989 | US4834982 Potassium-neutral salureticum with anti-hypertensive effect |
05/24/1989 | EP0317278A2 Proteolytic fragments and synthetic peptides that block the binding of von Willebrand factor to the platelet membrane glycoprotein Ib |
05/24/1989 | EP0317053A2 Trigramin- a platelet aggregation inhibiting polypeptide |
05/24/1989 | EP0316709A2 Proteinaceous derivatives containing iron in highly bioavailable form, preparation thereof and pharmaceutical compositions containing them |
05/24/1989 | EP0316456A1 Ester-substituted thienotriazolodiazepine compounds and their medicinal use |
05/24/1989 | CN1033070A Modified plasminogen activators |
05/23/1989 | US4833127 Novel CSF and method for obtaining the same |
05/23/1989 | US4832849 Liquid chromatography |
05/23/1989 | CA1254567A1 Substituted hexahydropyrrolo¬1,2-a|quinoline, hexahydro-1h-pyrido¬1,2-a|quinoline, hexahydrobenzo¬e|indene and octahydrophenanthrene cns agents |
05/23/1989 | CA1254557A1 (2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-b) quinazolinyl) oxyalkylamides |
05/23/1989 | CA1254518A1 Composition and method for treating mammalian acidosis |
05/18/1989 | WO1989004368A1 Novel human tissue-type plasminogen activator variant |
05/18/1989 | WO1989004324A1 Phosphoryled derivatives of cardiodilatine/anf peptides |
05/18/1989 | WO1989004306A1 Fused pyridazine compounds and their medicinal uses |
05/18/1989 | WO1989004168A1 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
05/18/1989 | DE3837550A1 Alkoxyderivate von ginkgoliden, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel Alkoxy derivatives of ginkgolides, process for their production and pharmaceutical compositions containing them |
05/18/1989 | DE3737917A1 Phosphorylierte derivate von cardiodilatin/anf-peptiden Phosphorylated derivatives of cardiodilatin / anf-peptides |
05/17/1989 | EP0316279A2 Ester derivatives of azacyclic hydroxycompounds |
05/17/1989 | EP0316068A1 Modified low molecular weight plasminogen activator and method of preparation |
05/17/1989 | EP0315968A1 Plasma and recombinant protein formulations in low ionic strength media |
05/17/1989 | EP0315698A1 Thieno(triazolo)diazepine compounds and medicinal application of the same |
05/16/1989 | US4831119 Blood clotting factors |
05/16/1989 | US4831046 Tetrazole derivatives of 1,3-dioxane and thromboxane A2 antigonizing use thereof |
05/16/1989 | US4831027 Imidazo-benzoxazinones, the preparation thereof and pharmaceutical compositions containing these compounds |
05/16/1989 | US4830857 Cosmetic and pharmaceutical compositions containing niosomes and a water-soluble polyamide, and a process for preparing these compositions |
05/16/1989 | CA1254230A1 Cycloalkane-indene- carboximidamide derivatives |
05/16/1989 | CA1254205A1 6-amidino-2-naphthyl benzoate compounds |
05/16/1989 | CA1254200A1 Compounds with a nitrogen-containing heterocyclic nucleus, their preparation and drugs in which they are present |
05/10/1989 | EP0315349A1 Phospholipase A2 inhibiting compositions and their use |
05/10/1989 | EP0315118A2 DNA coding for endothelin and use thereof |
05/10/1989 | EP0315115A2 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives, process for producing them and use thereof |
05/10/1989 | EP0315081A2 Anti-coagulating protein PP4-x, its preparation and use |
05/10/1989 | EP0315009A2 Chroman derivatives, process for their preparation and their use in medicines |
05/09/1989 | US4829078 Cerebral edema |
05/09/1989 | US4829065 Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives |
05/09/1989 | US4829052 Serine protease inhibitors |
05/09/1989 | US4827945 Magnetic resonance imaging |
05/09/1989 | CA1253862A1 N,n-disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo- ¬2,1-b|quinazolinyl)-oxyalkylamides |
05/09/1989 | CA1253803A1 Buccal and nasal compositions containing iron complexes of 3-hydroxy-4-pyrones |
05/05/1989 | WO1989003884A1 Interleukin-7 |
05/05/1989 | WO1989003874A1 Novel polypeptide compounds |
05/05/1989 | WO1989003838A1 Acyl deoxyribonucleoside derivatives and uses thereof |
05/05/1989 | WO1989003688A1 Amino acid composition for parenteral nutritional support and the use thereof |
05/05/1989 | WO1989001330A3 W-arylsulphonamidoalkanoic acids for treatment of thromboxane mediated diseases |
05/03/1989 | EP0314576A1 Tetra and pentapeptides with the sequence lysyl-arginyl-aspartyl, and their use as antithrombotics |
05/03/1989 | EP0314415A2 Interleukin-7 |
05/03/1989 | EP0313969A2 Tripeptide derivatives and antiplasmin agents containing the same |
05/02/1989 | US4827032 Intermediates for anticoagulants |
05/02/1989 | US4827017 Novel carbacyclins, processes for their production and their use as medicinal agents |
05/02/1989 | US4826864 Substituted imidazole derivatives useful as antihypertensive or antithromtic agent or divretic |
05/02/1989 | US4826855 Thieno pyridines and their use as anti-hypertensive agents |
05/02/1989 | US4826813 4'-Methyl-β-mercapto-β,β-cyclopentamethylenepropionic acid vasopressin antagonists |
05/02/1989 | US4826811 Crosslinked, pyridoxylated hemoglobin free of tetramers |
05/02/1989 | CA1253511A1 3-hydroxyflavones; their preparation and therapeutic application |
05/02/1989 | CA1253493A1 Bicycloheptane substituted ethers |
04/27/1989 | DE3835099A1 Pharmazeutische zusammensetzung Pharmaceutical composition |
04/26/1989 | EP0313288A1 Imidazole derivatives, process for their preparation and their use as alpha 2-adreno-receptor antagonists |
04/26/1989 | EP0312942A2 Polypeptides with a prourokinase activity, their production and use |
04/26/1989 | EP0312941A2 Polypeptides with a prourokinase activity, their production and use |
04/26/1989 | EP0312913A2 Use of paf-antagonists for the preparation of a medicament and method for the determination of their binding-activity |
04/26/1989 | EP0312598A1 Peptide functioning to accelerate activation of protein c with thrombin |
04/26/1989 | EP0194416B1 Thieno-triazolo-1,4-diazepino-2-carboxamides, process for their preparation and pharmaceutical compositions |
04/25/1989 | US4824851 Pyrimidones as cardiotonic, anti hypertensive, cerebrovascular vasodilator and anti-platelet agents |
04/25/1989 | US4824835 Isoquinolinedione derivatives, pharmaceutical compositions and methods of use |
04/24/1989 | EP0320507A4 Scaled-up production of liposome-encapsulated hemoglobin. |
04/20/1989 | WO1989003216A1 Use of 5-aminosalicyclic acid (5-asa) for the production of a pharmaceutical preparation for use in reperfusion treatment |
04/19/1989 | EP0312338A1 Sulfamoyl-2-benzofurancarboxylic acid derivatives, their preparation and use |
04/19/1989 | EP0312086A2 Polysulfuric esters of amides of bis-aldonic acids and their derivatives, a method for their preparation and a drug |
04/19/1989 | EP0312055A2 6-Fluoroprostaglandins |
04/19/1989 | EP0312041A2 2,4-Disubstituted 1,3-dioxolanes |
04/19/1989 | EP0312040A2 2,4-Disubstituted derivatives of tetrahydrofuran |
04/19/1989 | EP0193013B1 Benzimidazolyl-pyridazinones |
04/18/1989 | US4822815 Dioxane hexenoic acids |
04/18/1989 | US4822807 Pharmaceutical composition containing a stable modification of torasemide |
04/18/1989 | CA1252787A1 Substituted 5-(2-amino-phenylthio)-6-amino- pyrimidinone |
04/18/1989 | CA1252783A1 Pteridines, processes for preparing them and their use as intermediate products or as pharmaceutical compositions |
04/18/1989 | CA1252781A1 Allenic prostacyclins |
04/18/1989 | CA1252744A1 Ultrapurification of factor ix and other vitamin k- dependent proteins |
04/12/1989 | EP0311589A1 Modified tissue plasminogen activator |